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Abstract
Cloning and sequencing of 5.5kb deletion at chromosome 11q13.1 from the HeLa cells,
tumorigenic hybrids and two fibroblast cell lines has revealed homologous recombination between
AluSx and AluY resulting in the deletion of intervening sequences. Long-range PCR of the 5.5kb
sequence in 494 normal lymphocyte samples showed heterozygous deletion in 28.3% of African-
American ancestry samples but only in 4.8% of Caucasian samples (p<0.0001). This observation
is strengthened by the copy number variation (CNV) data of the HapMap samples which showed
that this deletion occurs in 27% of YRI (Yoruba – West African) population but none in non-
African populations. The HapMap analysis further identified strong linkage disequilibrium
between 5 single nucleotide polymorphisms and the 5.5kb deletion in the people of African
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ancestry. Computational analysis of 175kb sequence surrounding the deletion site revealed
enhanced flexibility, low thermodynamic stability, high repetitiveness, and stable stem-loop/
hairpin secondary structures that are hallmarks of common fragile sites.
Introduction
We have previously identified a 300kb minimal area of 11q13.1 deletion in cervical tumors,
which overlapped with deletions found in other human tumors [1] (Figure 1). Detailed
microsatellite analysis of the HeLa cells (a cervical cancer cell line) identified an interstitial
deletion of 2.3Mb within the q13.1 locus of one chromosome 11 and a 5.5kb deletion in the
second copy of chromosome 11 [1, 2]. Thus, the HeLa cells showed homozygous loss of the
5.5kb sequences. HeLa cell derived tumorigenic hybrid cell lines and a primary cervical
tumor also showed homozygous loss of these sequences (represented by the STS marker
D11S913) [3]. Surprisingly, we also found heterozygous loss of the same sequences in two
fibroblast cell lines (GM00077 and GM00468). However, the molecular nature of the
breakpoint sequences leading to these deletions has not yet been determined. As HeLa cells
and GM00077 are derived from individuals of African ancestry, it is not known whether the
5.5kb sequence deletion is a cell line phenomenon or is a common event in individuals of
this ancestry.
Chromosome 11q13.1 is a region known to contain fragile sites that are prone to breakages.
Cytogenetic analysis has revealed two types of fragile sites in the human genome: rare and
common. Rare fragile sites are found in less than 5% of cells grown under specific culturing
conditions and are molecularly characterized by the expansion of unstable repeats: Folate
sensitive rare fragile sites contain CCG repeats, whereas distamycin A and
bromodeoxyuridine (BrdU) sensitive sites contain AT-rich mini-satellite sequences [4, 5].
These types of fragile sites only occur in a small percentage of the population, are heritable,
and have been associated with diseases such as mental retardation and neurodegenerative
diseases. The best examples of rare fragile sites are FRAXA (at Xq27.3), associated with the
inactivation of FMR1, and FRAXE (at Xq28) associated with the inactivation of FMR2 [4–
6].
In contrast, common fragile sites are found in greater than 5% of treated cells and are
considered a normal part of chromosomal structure. Instead of an expansion of triplet
repeats, common fragile sites are characterized by repetitive, GC poor and flexible
sequences. It has been shown that such sequences facilitate the formation of stable
secondary structures during DNA replication, thus causing replication fork stalling and
DNA breaks [7–9]. Evidence suggests that a similar mechanism operates at rare fragile sites:
the expansion of CCG or AT mini-satellite also facilitates the formation of non-helical
secondary structures [7]. Thus the formation of a secondary structure during DNA
replication appears to be an important underlying cause of fragility.
We have previously performed sequence analysis and determined that sequences within the
cervical cancer deletion locus are GC poor and highly repetitive, similar to those found at
other common fragile sites [10]. While such sequences are implicated in genetic instability,
evidence for their direct involvement in deletions is not yet known. In this study, we
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performed molecular and computational analysis to understand the fragile nature of the
11q13.1 locus. We find that 11q13.1 sequences are thermodynamically flexible and
unstable, and prone to the formation of complex secondary structures, characteristics that are
hallmarks of common fragile sites. We also demonstrate that the HeLa cell 5.5kb deletion is
characterized by the presence of two direct Alu repeats at the deletion breakpoints, which
directly implicates repetitive sequences to the deletion event. We further demonstrate that
the heterozygous deletion of the 5.5kb sequence is found in the normal lymphocytes of the
general U.S. population and is present in higher frequency in people of African American
ancestry.
Material and Methods
Cell Lines and blood samples
Publicly available fibroblast cell lines GM00023, GM00077, GM00468, and GM05399 were
obtained from the cell line collection of Coriell Institute for Medical Research (Camden,
NJ). While GM00023 was derived from a normal 31-year old Caucasian female, GM05399
was derived from a 1-year old Caucasian male. GM00077 was derived from a 1-year old
male of African ancestry affected with the recessive disorder, Tay-Sachs disease. The age
and ancestry of the GM00468 cell line derived from a normal male is not known. Cervical
cancer cell lines HeLa, C4I, MS751, SiHa, C33A and HT3 were obtained from the ATCC
cell line repository (Manassas, VA). HeLa cell derived tumorigenic hybrids were obtained
from Dr. Eric J. Stanbridge of UC Irvine, CA. All cell lines were grown in MEM (Minimal
Essential Media) medium supplemented with 10% FCS (Fetal Calf Serum). HeLa and C4I
contain HPV 18 sequences, and MS751 and SiHa contain HPV 16 sequences. C33A and
HT3 cell lines are HPV negative. Blood samples were collected from the blood bank of the
VAGLAHS, West Los Angeles using an internal IRB-approved protocol. High molecular
weight genomic DNA was isolated using established protocols.
Ethics statement
There was no contact with subjects in the collection of blood samples from the blood bank.
Bacterial artificial chromosomes (BACs)
Bacterial artificial chromosomes (BACs) were isolated from a human genomic BAC library
[10, 11]. Sequencing of BACs 41I21 and 152L21 was performed at the University of
Oklahoma Genome Center and the sequences of the other BACs were obtained from the
NCBI Human Genome database. The Genbank [http://www.ncbi.nlm.nih.gov/]nucleotide
accession numbers for the BACs b41I21, b152L21, b755F10, b867G23, and bCTD-3074O7
are AC008102, AC069080, AP000759, AP001107, and AP002748 respectively.
Oligonucleotide primers and polymerase chain reaction (PCR)
The genomic sequence of 700kb of chromosome 11q13.1 was derived from the genome
database. Primers were identified from the genomic sequences using the Primer3 program of
the MIT Whitehead Institute. Primers identified in our earlier investigations were also used
[10]. PCR was performed in 25µl reactions with 100ng of genomic DNA using Amplitaq
(Applied Bio-systems, Inc., CA) DNA polymerase. PCR was performed using the
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established protocol and products were analyzed on 8% polyacrylamide gels, stained with
ethidium bromide, and visualized under ultra-violet light [10].
Long-range PCR
For amplification of sequences greater than 1.8kb, a long-range PCR method was employed.
The system uses a high fidelity enzyme, Takara Ex Taq DNA Polymerase (PanVera, Inc.,
WI), longer primer sets (23–26 nucleotides) with higher melting temperatures, and a hot-
start PCR method. The forward and reverse primers used for the 7.3kb product are as
follows: Forward - 5’ GGA AAG GTC CCA GAA AGA AGA TCA AG 3’ and Reverse - 5’
TGG CCA GTG TGG AGA CCA AGC TGC 3’. Typically, 500ng of genomic DNA or
50ng of BAC DNA were used in a 50µl reaction. The samples were denatured for 3 minutes
and a step-down annealing method was used. The cycles consisted of denaturation at 94°C
for 45 seconds, annealing at 69°C for 10 cycles, 68°C for 11 cycles, and 66°C for 12 cycles
for 30 seconds each, and extension at 72°C for 5 minutes. A final extension was performed
at 72°C for 10 minutes. PCR products were analyzed on 1% agarose gels, stained with
ethidium bromide, and visualized under ultra-violet light.
Sequencing
PCR products were purified using the QIAquick PCR Purification Kit (Qiagen, CA) and
sequenced using the Sanger Dideoxy Sequencing Protocol.
Sequence Analysis
Repeat and GC content of sequences was calculated using the REPEATMASKER program
(http://www.repeatmasker.org/) which screens DNA sequences against a library of repetitive
elements. The slow/most-sensitive setting was used for all analyses, with large sequences
divided into 20kb segments for analysis. DNA helix flexibility and stability was calculated
using the FLEXSTAB (http://bioinfo.md.huji.ac.il/marg/Flexstab/) and TWISTFLEX (http://
margalit.huji.ac.il/TwistFlex/) programs [7, 12]. In brief, the flexibility parameter that was
used measures potential local variation in the DNA structure, expressed as fluctuations in
the TWIST angle [13]. The helix stability is based on the sequence-dependent free energy
values of the helix-to-coil transition and was expressed in Kcal/mol. Dinucleotide energy
values were determined along the window and averaged by the window size. Secondary
DNA structure was identified using the MFOLD program (http://mfold.rna.albany.edu/?
q=mfold) [13, 14].
Southern blot hybridization analysis
Genomic DNAs were digested with EcoR1 restriction enzyme, separated on 1.0% agarose
gels in Tris-acetate buffer, pH 7.85 and the DNA fragments were transferred onto nylon
membranes in 20 X SSC buffer, pH 7.0. Blots were hybridized using 32p-labelled probes in
the presence of salmon sperm non specific DNA, washed twice in 2 X SCC, 0.2% SDS
buffer, twice in 0.2 X SSC, 0.1% SDS buffer at 65 °C for 30 minutes each time and then
exposed to x-ray film for 2 to 7 days [2].
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Northern blot hybridization analysis
Pre-made normal tissue and cancer cell line poly (A) RNA blots were purchased from
Clontech, Inc. (Palo Alto, CA) and Ambion, Inc. (Austin, TX). Hybridizations were
performed with 32p-labelled probes at 42°C and exposed to X-ray films for 2–7 days as
described [10].
Fluorescence in situ hybridization
The 5.5kb sequence or the control probes (6.6kb HRAS probe localized to the short arm of
chromosome 11 (11p15) and a 5kb probe, representing MLL gene at 11q23) were labelled
and hybridized to metaphase spreads as previously described [2, 15]. Briefly, metaphase
spreads were prepared by standard cytogenetic procedures. Probes were labeled by nick
translation with digoxigenin- 11-dUTP (Boehringer Mannheim, Indianapolis, IN) following
the manufacturer's protocol. Hybridization and washes were performed under identical
conditions of stringency. At least 20 metaphase spreads were analyzed.
UCSC Genome browser analysis for the detection of copy number variations (CNVs)
The region of chromosome 11, 65689011–65696252 (hg18), was queried in the UCSC
Genome Browser (http://genome.ucsc.edu/). The 'DGV Structural Variation' track, under
'Variation and Repeats', was turned on to view CNVs previously reported to the Database of
Genomic Variants. The source (publication) and population distribution of each reported
CNV overlapping the queried region was obtained using the associated variation ID.
HapMap Genotype Data and LD Analysis
The HapMap Phase III SNP genotype data was downloaded in PLINK (PED/MAP) format
from the International HapMap Project website (http://hapmap.ncbi.nlm.nih.gov/downloads/
index.html.en). The genotype data of chromosome 11 (71,098 SNPs) for 166 Yoruba
individuals was extracted for analysis.
LD between the deletion and the HapMap Phase III SNPs on chromosome 11 was calculated
using PLINK [16] (http://pngu.mgh.harvard.edu/~purcell/plink/). The resulting r2values for
SNPs within 1MB of the deletion were plotted using ggplot2 [17] (http://ggplot2.org/)
graphics package for R.
SNP Annotation and Proxy Search (SNAP) [18], from the Broad Institute, was used to
evaluate LD within different populations from the HapMap3 (Phase II) data. Six populations
were evaluated: three of African ancestry (Yoruba (YRI), Luhya in Webuye, Kenya (LWK),
& African ancestry in South-west USA (ASW)) and three of non-African ancestry (Utah
residents with Northern and Western European ancestry (CEU), Tuscans in Italy (TSI), &
Japanese in Tokyo, Japan/Han Chinese in Beijing, China (JPT/CHB)). The r2 threshold for
LD was set to 0.8 with a distance limit of 500kb from the proxy SNP.
Haploview [19] (http://www.broadinstitute.org/scientific-community/science/programs/
medical-and-population-genetics/haploview/haploview) was used to assess LD patterns
across a 200kb region of chromosome 11 overlapping the region of interest. Plots were
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generated for the 6 populations (YRI, LWK, ASW, CEU, TSI, & JPT/CHB) to compare LD
patterns between populations of African ancestry and populations of non-African ancestry.
Statistical methods
We evaluated the significance of alterations in the flexibility values observed in the 175kb
region, between 225–400kb of the 700kb 11q13.1 genomic region (Figure 1) compared to
the region outside this interval using a permutation simulation. The simulation was designed
to evaluate the likelihood of identifying a region of this size (175kb) of altered flexibility
values assuming we were free to choose the optimal region of difference. In each run of the
simulation we first permuted the location labels for each data point. Second, we computed t-
statistics comparing sequential regions of size 175kb versus all other regions in the data. For
each run this involved examining 30 possible regions of size 175kb starting at each multiple
of 25kb. Next, we identified the maximal t-statistic for each simulation run across all 30
regions evaluated. The set of the maximal t-statistics from the set of permutations then
formed the permutation distribution for our observed t-statistic. The observed t-statistic for
comparing flexibilty values in the 175kb region versus the remaining region had a value
256.6. In 1000 simulations the largest maximal permuted t-statistic was 4.2. This indicates
that the p-value of the observed finding is less than 0.001. This permutation simulation
controls for the possible bias that could have arisen as the specific region examined was not
apriori defined.
Results
Characterization of the HeLa cell 5.5kb deletion breakpoint at chromosome 11q13.1
We have previously localized the HeLa cell homozygous deletion to a ~5.5kb interval of
chromosome 11q13.1 [3] (Figure 1). While one of the deletions was 5.5kb, the other
deletion was 2.3Mb. To identify the precise deletion breakpoints of the 5.5kb sequence, we
designed primers from outside of the deletion (approximately 1kb from each of the retained
markers) and attempted amplification of a 7.3kb genomic sequence (Supplemental Figure 1).
PCR on the BAC 152L21, which contains the sequences of this area, yielded the expected
7.3kb PCR product (Figure 2A). The 7.3kb product was also observed in four normal
lymphocytes, and two different primary fibroblast cell lines, GM00023 and GM05399
(Figures 2A and 2B). Two normal fibroblast cell lines (GM00077 and GM00468) yielded
both a 7.3kb product and a 1.8kb product, suggesting heterozygous deletion of the 5.5kb
sequence (Figure 2A). However, seven different HeLa cell lines and two HeLa cell derived
tumorigenic hybrid cell lines yielded only the smaller 1.8kb product, indicating homozygous
deletion of the 5.5kb sequence (Figure 2C). Analysis of five other cervical cancer cell lines
showed a normal 7.3kb product (Figure 2D), indicating that 5.5kb deletion is specific to the
HeLa cells.
To confirm the PCR results, we performed Southern blot hybridizations. A 2.5kb PCR probe
representing the sequences within and outside of the deletion gave rise to an expected 5.5kb
EcoRI fragment in two normal fibroblast cell lines (GM00023 and GM05339) (Figure 2E).
However, only a deletion specific 7kb fragment, indicative of homozygous deletion, was
seen in the HeLa cells. The fibroblast cell lines GM00468 and GM00077 yielded the
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expected 5.5kb and the 7kb fragments, confirming the heterozygous deletion of the 5.5kb
sequence in these two cell lines. As a further confirmation, FISH (Fluorescence in situ
hybridization) studies were undertaken using the 5.5kb probe. The analysis yielded
hybridization of the 5.5kb probe to chromosome 11q13.1 sites in a normal lymphocyte
sample (Figure 2F). The fibroblast cell line GM00077 showed 5.5kb probe hybridization to
only one chromosome 11 in all the metaphase spreads examined clearly indicating
heterozygous deletion of these sequences. While the control probes HRAS (11p15) and MLL
(11q23) hybridized to two chromosome 11s of the HeLa cells, there was no hybridization of
the 5.5kb (11q13.1) probe confirming homozygous deletion of these sequences in the HeLa
cells.
To characterize the deletion breakpoints, we sequenced the 1.8kb PCR product from the
HeLa cells; HeLa cell derived tumorigenic hybrids, and the fibroblast cell lines GM00468
and GM00077. A sequence comparison using the BLAST and Repeat Masker programs
revealed a 308bp Alu repeat at both the centromeric and the telomeric ends of all the
deletions. The two repeats are 85% homologous (with the core Alu sequence being 95%
identical) and occur in the direct orientation at the break site. Using SNPs from the two Alus
we were able to pinpoint the precise sites of breakage to within a few base pairs, indicating
that the deletion is indeed 5.5kb (Figure 1). More importantly, sequences at breakpoint sites
showed that the deleted samples contained a novel hybrid Alu (derived from AluSx at the
centromeric end and AluY at telomeric end – Figure 1), providing strong evidence for a
homologous recombination event giving rise to the observed interstitial deletion. The
presence of similar deletion breakpoints in all examined samples indicated that this is either
a deletion hotspot or a heritable genetic element.
Identification of the 5.5kb heterozygous deletion in the general population
To determine whether the general population also harbors this deletion, we assayed blood
samples obtained from the VA West Los Angeles for the deletion using a long-range PCR
protocol. We found that 47 of 494 (9.5%) of the lymphocyte samples showed heterozygous
deletion, indicating that nearly 1/10 of the U.S. general population harbors this deletion in
one of their chromosome 11s (Table 1, Figure 3A). Semi-quantitative PCR analysis and
Southern blotting performed on 100 of these samples confirmed the deletion in these
lymphocyte samples (Figures 3B and 3C).
Enrichment of the 5.5kb heterozygous deletion in individuals of African-American ancestry
Since the HeLa cells and GM00077 are both of African ancestry, we hypothesized that this
deletion might be found in greater frequency in the African-American (AA) population. We
thus analyzed the lymphocyte samples for the relationship to ethnicity. We observed the
deletion in 26/92 (28.3%) of AA DNA samples while only in 6/126 (4.7%) of Caucasian
samples indicating an enrichment of the deletion in people of AA ancestry (p<0.0001)
(Table 1). To confirm this observation, we analyzed another subset of 70 lymphocyte
samples specifically from people of AA origin by semi-quantitative PCR and Southern blot
hybridization. We found heterozygous deletion in 20 (28.6%) of this test case (Figures 3D
and 3E), providing further proof that the 5.5kb deletion segregates within this population.
These results, therefore, indicate that African-American individuals show a 3-fold
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enrichment of the deletion in comparison to the general population and a 7-fold enrichment
in comparison to the Caucasian population. In the second subset of 70 AA samples we found
two of five individuals treated for cancer contained homozygous deletion of the 5.5 kb
sequence (Supplemental Table 1). Homozygous deletion was not observed in 15 of the non-
tumor samples. Although there is also a higher frequency of heterozygous deletion
associated with cardiomyopathy, a large dataset of AA samples is required to confirm and
extend an association to a clinical phenotype in the AA population.
Given the high frequency of the deletion in lymphocyte samples, we reasoned that the
deletion likely exists as a heritable genetic element (as opposed to a reoccurring de novo
event). To test this possibility, we analyzed a two-generation family obtained from the
Coriell Institute (Camden, NJ) and found the father and children to harbor the heterozygous
deletion indicating that the deletion is heritable (Figure 3F). This family was found to be of
African ancestry.
Identification of the 5.5kb heterozygous deletion in the YRI population of the HapMap
studies
To determine whether the identified deletion interval [chr11:65690475–65695907 (hg18)]
has previously been reported in the Database of Genomic Variants (DGV), the region was
queried in the UCSC Genome Browser (http://genome.ucsc.edu/) using the 'DGV Structural
Variation' track. We noticed that the 5.5kb deletion was seen in previous HapMap
investigations [20–25]. The variation IDs were used to gather information about each copy
number variation (CNV) from the Database of Genomic Variants (http://projects.tcag.ca/
variation/), including the publication source, size, frequency, and population distribution. As
reported by Conrad et al [20], from their analysis of 450 HapMap individuals (Figure 4 –
variation ID 65975), the 5.5kb deletion was observed in 27% (49 of 180) of the YRI
population, in 0% (0/180) of the CEU population, and in 0% (0/90) of the JPT/CHB
population (Figure 4). The population distribution of this deletion within the HapMap
dataset is consistent with our results that the 5.5kb deletion is prevalent in people of African
ancestry.
To determine whether the 5.5kb deletion in this region was a de novo event or part of a
heritable event, the pedigree information for the 166 YRI Hapmap samples was obtained
from the Hapmap ftp site (ftp://ftp.ncbi.nlm.nih.gov/hapmap/phase_3/
relationships_w_pops_051208.txt) and the deletion status for each individual was
determined based on the data from Conrad et al [20]. Thirteen of the full trio families
showed that this deletion is present in the child (Supplemental Table 2). In all thirteen
families, at least one parent carries the deletion as well, providing evidence toward the
heritable nature of this deletion event. In one family Y010, the child carries the deletion.
However, it is not a full trio because the paternal data is not available. From this
information, it can be inferred that the deletion exists predominantly as a stable heritable
element supporting our results from the two-generation family.
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Linkage Disequilibrium (LD) analysis
Analysis of the HapMap populations has identified the 5.5kb deletion within the 1st intron of
the PACS1 gene, a cytoplasmic trafficking protein [26, 27], on chromosome 11 to be
prevalent in the Yoruba African population. To identify any SNPs on chromosome 11 which
may be in strong linkage disequilibrium with the 5.5kb deletion, LD analysis was performed
with PLINK. The data from Conrad et al [20] provided the copy number of this variation for
each individual (Supplemental Table 3). Using this information, knowing that there were not
any SNPs residing within the deletion region, each copy number was attributed a genotype
for LD analysis: 0 copies = A/A, 1 copy = A/G, 2 copies = G/G. The results included five
SNPs on chromosome 11 with r2> 0.8, and all five SNPs appear to be in perfect LD with the
deletion, r2 = 1 (Figure 5A–B). Next, using SNAP, we assessed the LD between these 5
SNPs in other populations. One of the five SNPs (rs11227418) served as a proxy to evaluate
the LD in six HapMap (Phase III) populations (three of African ancestry - YRI, LWK, &
ASW, and three of non-African ancestry - CEU, TSI, & JPT/CHB). In YRI, LWK, & ASW,
all four SNPs were in perfect LD with rs11227418, having r2 values equal to 1
(Supplemental Figure 2A). However, in the three non-African populations, CEU, TSI, &
ASW, there were no data to be plotted because, as it turns out, the five SNPs are
monomorphic in these populations and LD cannot be evaluated (Supplemental Figure 2B,
Supplemental Table 4).
To get a more in-depth explanation for this, we used Haploview to assess LD in a 200kb
region encompassing the 5.5kb deletion, chr11:65,600,000–65,800,000, in all six
populations. The haploview plots showed a distinctly different LD pattern in the populations
of African ancestry compared to non- African populations (Supplemental Figure 3). There
are a greater number of monomorphic SNPs in this region in non-African populations,
including the 5 SNPs in strong LD with the 5.5kb deletion. The population specific LD
pattern in this region supports the observation of a population specific variation in
individuals of African ancestry. The allele frequencies of the five SNPs, obtained from
dbSNP (http://ncbi.nlm.nih.gov/projects/SNP/), also convey the population specific variation
of these five polymorphisms (Supplemental Table 4). The two West African populations,
YRI & LWK, contain all three genotypes, whereas the Africans of Southwest USA
population contains two of the genotypes, and the non-African populations are
monomorphic.
Evaluation of the specific genotypes in each YRI individual for the five SNPs in strong LD
with the deletion showed that a specific haplotype could be observed in individuals carrying
the deletion versus individuals that did not carry the deletion (Supplemental Table 3). 122
individuals that did not carry the deletion were homozygous G/G for all five SNPs. All
individuals that carried the deletion had a common specific haplotype rs11227418-A,
rs495684-T, rs561948-A, rs501690-A, rs501979-A. A haplotype consisting of A/G, T/G,
A/G, A/G and A/G for the five SNPs is thus observed in 42 individuals with a heterozygous
deletion and a haplotype of A/A, T/T, A/A, A/A and A/A is observed in four individuals
(NA18867, NA19146, NA19185, and NA19239) with homozygous deletion of the 5.5kb
sequence. The deletion frequencies agreed with the frequencies expected from the Hardy-
Weinberg equilibrium calculations. The expected frequencies of heterozygous and
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homozygous deletions are 42.46 and 3.76 respectively (Supplemental Figure 4). The
observed frequencies are 42 and 4 indicating a clear agreement to the expected values.
Identification of fragile-like sequences at the 11q13.1 locus
We have previously reported that the sequences surrounding the homozygous deletion are
GC poor and highly repetitive, similar to those found at other common fragile sites (Figure
6A) [10]. Since thermodynamically unstable and flexible sequences are also associated with
common fragile sites, we analyzed a 700kb region encompassing 300kb minimal area of
primary cervical tumor deletion using the FLEXSTAB and TWISTFLEX computational
programs. These programs have been used in previous fragile site studies to determine
potential local variations in DNA structure and stability based on sequence dependent
dinucleotide twist angles and free energy values [7, 12, 13]. Our analysis shows significant
DNA instability and flexibility for a 175kb region surrounding the 5.5kb deletion (near
marker D11S913) similar to that observed at other common fragile sites (p<0.001) (Figures
6B and 6C). Notably, this 175kb locus overlaps with a 120kb region we have previously
shown to contain the lowest GC content and the highest overall repeat content for the entire
700kb analyzed sequence [10].
Since such sequences can result in the formation of secondary structures during DNA
replication that are thought to be the molecular basis of fragility, we analyzed the 120kb
region for such structures using the MFold program [7, 9]. Our analysis reveals a large
number of inverted repeats (including within the 5.5kb deletion locus) that are predicted to
form highly stable stem-loop/hair-pin structures (Figure 7A–C). Due to the highly repetitive
nature of the locus, secondary structures of unprecedented size and complexity occur, often
spanning hundreds or even thousands of base pairs (Figure 7B–D).
Our attempts at the functional analysis of the 5.5kb sequence were unsuccessful due to the
instability of this sequence cloned in various vectors. Also, we could not identify coding
sequences for a miRNA within this 5.5kb sequence. Thus, we focused our attention on the
expression of PACS1 gene mapped to this locus. We have previously shown that the
expected 4.5kb transcript of the PACS1 gene was present in the HeLa cells and other tumor
cell lines [10]. We have also shown the expression of an 8.0kb transcript in the HeLa cells
and tumor cell lines indicating the presence of spliced variants of the PACS1 gene. Due to
low level expression of this 8.0kb variant, we could not clone this transcript. A 2.5kb and a
121bp probe mapped 16kb and 1kb proximal to 5.5kb deletion showed the presence of
transcripts in normal tissues confirming the possibility that spliced variants of PACS1 exist
in normal tissues (Supplemental Figure 5). Protein analysis has shown that the PACS1
protein is over expressed in cervical cancer cell lines and primary tumors (data not shown).
Thus, the available data suggests that PACS1 is aberrantly expressed in the HeLa cells and
primary cervical tumors.
Discussion
Regions enriched for repetitive elements have previously been shown to be genetically
unstable [28–30]. Alu and LINE elements have been implicated in genomic rearrangements
leading to numerous human diseases [31, 32]. Thermodynamically unstable and flexible
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DNA sequences are more prone to adopt single-stranded conformation and form secondary
structures such as hairpins or stem-loops [7]. Such structures are stabilized by the presence
of inverted repeats and can slow or stall the replication fork during DNA replication. This
can produce double stranded breaks and other genetic abnormalities, and is thought to be
molecular mechanisms behind common fragile sites [7, 33]. Cells repair such potentially
fatal lesions by NHEJ (non-homologous end joining) or homologous recombination [34, 35].
However, direct repeats also provide ready targets for illegitimate homologous
recombination, which can lead to deletions and genomic rearrangements.
Thus it is likely that the repeat rich sequences cause genetic instability at this locus in a two-
fold manner: 1) Inverted repeats stabilize secondary single-stranded DNA configuration
resulting in replication fork stalling and DNA breaks; 2) Direct repeats act as sites of
illegitimate homologous recombination in the repair process, resulting in deletions and
genomic rearrangements.
It is interesting to note that cervical and nasopharyngeal tumors with 11q13.1 deletions have
p53 and/or other repair proteins inactivated, and thus might be prone to such
rearrangements. For instance, cells lacking p53 have been shown to have a substantially
higher frequency of illegitimate homologous recombination which can cause deletions such
as the one in the HeLa cells [36]. Further, loss of the ATR (ATM related) kinase, another
important DNA repair protein, appears to be sufficient for induction of common fragile sites
under normal conditions [37]. Our preliminary studies indicate that PACS1 protein might be
playing a role in DNA replication and overexpression of this protein could therefore be a
cause of tumor associated genomic rearrangements (data not shown).
Here we provide evidence that the direct repeats have recombined in the HeLa cells,
resulting in the deletion of the interstitial sequences and giving rise to a hybrid Alu
containing SNPs from the distal and proximal Alu repeats. Moreover, we show that the
surrounding sequences are prone to the formation of singe-stranded secondary structures.
Additionally, we have found that the 5.5kb deletion also occurs in 9% of the general US
population but in 28% of people of African-American ancestry and is heritable. These
results are also supported by the observation of this deletion in YRI individuals of the
HapMap studies.
Since chromosome 11q13.1 contains fragile sites, an inevitable question arises: do the 120kb
sequences represent common or rare (or both) fragile sites? From our data, it appears that
these sequences have all of the major hallmarks of a common fragile site: high frequency of
repeats, low GC content, flexible sequences, potential secondary structures, and high
incidence of genetic alterations in cancer. Moreover, much like the FRA3B and FRA16D
common fragile sites, the repeat rich and GC poor nature of the 120 kb sequences are also
conserved in the mouse and rat [10, 35,38]. Therefore, our results indicate that the deletion
sequences identified here most likely represent a common fragile site. This is further
strengthened by the report that the rare fragile site FRA11A is caused by expansion of a
CCG repeat in the 5' end of the C11orf80 gene, located 660kb telomeric from D11S913
[39]. Further, loss of heterozygosity studies has identified a number of tumor suppressor
genes at chromosome 11q13.1 [40–43]. We have also mapped cystatin E/M tumor
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suppressor gene to sequences 200kb proximal to 5.5kb sequence and have observed
homozygous deletion of exonic sequences in primary tumors confirming fragility of this
region [43]. While the 5.5kb deletion may be heritable in the AA population, sequences
surrounding this site may be fragile in the general population
One unanswered question still remains: exactly how far does the fragility at 11q13.1 extend?
Experimental data suggest that it is not limited to the 120kb interval examined. For instance,
the 300kb minimal area of cervical cancer deletion extends an additional 175kb centromeric
to this region. Moreover, viral integrations, which represent possible locations of common
fragile sites, have also been reported for different regions of 11q13.1. Notably, the number
one hot spot of integration for HIV and ERV9 (endogenous retro virus 9) has been mapped
to a region approximately 1.5Mb centromeric of D11S913 [44, 45]. Moreover, the Hepatitis
B Virus (HBV) has also been shown to repeatedly integrate at a site approximately 1.1Mb
telomeric of D11S913 [46]. Since viral integrations are hallmarks of common fragile sites,
these results suggest that the common fragile site FRA11H at 11q13.1 (http://
www.ncbi.nlm.nih.gov/projects/mapview/maps.cgi?TAXID=9606&CHR=11&MAPS=ugHs
%2Cgenes%2Cgenec-r&QSTR=2446%5Bgene_id%5D&QUERY=uid
%28-2146581571%29&BEG=11q13.1&END=11q13.1&oview=default) could lie in a
2.6Mb distance between the two viral integration sites. Sequence analysis of this larger
interval indeed reveals the presence of two additional flexible/unstable regions (75kb and
100kb in length) that are also highly repetitive and GC poor (data not shown). These sites
occur 650kb and 1Mb telomeric of D11S913 and show remarkable similarities to the
unstable 120kb sequences reported in this investigation. Additionally, sequences near the
viral integration sites also appear to be particularly flexible: a 50kb region near the HBV
integration site and a 100kb region near the HIV/ERV9 integration site each contain five
peaks of significant flexibility. It is likely that these interrupted local hotspots of flexible/
unstable and repetitive sequences in the 2.6Mb regions contribute to the overall fragility of
the 11q13.1 locus.
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We have demonstrated heterozygous deletion of 5.5kb sequence on chromosome 11q13
in a specific population, here in African American (AA) population.
This polymorphism is a founder effect from the Yoruban population, an ethnic group of
southwestern Nigeria.
We have also shown single nucleotide polymorphisms (SNPs) closely linked to the
heterozygous deletion.
The deletion sequences or the SNPs could be used for association studies in diseases
prevalent in the AA population.
We also demonstrate that the region surrounding the heterozygous deletion sequence is
fragile, amenable to breakage from carcinogens.
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HeLa cell deletion breakpoints at proximal chromosome 11q13.1. We have previously
mapped one of the HeLa cell allelic deletions to a 2.3Mb and a second allelic deletion
between markers 5.5kb1 and EST F05086, an interval of 5.5kb. These two deletions overlap
yielding a homozygous deletion of 5.5kb sequence in the HeLa cells. The AluSx and AluY
sequences at the 5.5kb breakpoints are represented in bold letters. Note the homologous
repeat sequence at the centromeric and telomeric ends of the deletion. The vertical upward
arrows represent the breakpoint sites. The red dots represent the intervening sequences. The
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coordinates of deletion in the UCSC browser (hg18) are also shown. Known ESTs
(expressed sequence tags) are also indicated. Probes used for Southern blot hybridizations
are shown in red horizontal lines. FRA11H is mapped between proximal to MEN1 and
100kb distal to PACS1, a distance of 2.6Mb. Map is not drawn to scale.
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Long-range PCR confirming 5.5kb deletion in the fibroblast and HeLa cell lines. PCR
performed with primers localized outside of the 5.5kb deletion shows A) the presence of the
expected 7.3kb product in the BAC 152L21 and in normal fibroblast cell lines GM00023
and GM05399. Two other fibroblast cell lines GM00077 and GM00468 contain a 1.8kb
product in addition to the 7.3kb product. The high intensity of the 1.8kb product in
GM00077 and GM00468 represents a preferential amplification of the shorter PCR product.
The results therefore indicate heterozygous deletion of 5.5kb sequences from these two cell
lines. B) PCR product of 7.3kb is also seen in four normal lymphocytes, C) Seven different
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isolates of HeLa cells and tumorigenic hybrids 1-1-4TR and CGL4 contain only the 1.8kb
product confirming homozygous loss of the 5.5kb sequences in these cell lines, D) Five
other cervical cancer cell lines show the presence of 7.3kb product indicating absence of
deletion in these cells. E) Southern blot hybridization to a 2.5kb probe representing
sequences outside and inside of deletion shows the presence of the expected 5.5kb fragment
in the two normal fibroblast (GM00023, GM05399) and in two cervical cancer (SiHa, C41)
cell lines (indicated by the arrow). The HeLa cell DNAs hybridize to a rearranged 7kb
fragment representing the deletion. Two other fibroblast cell lines (GM00077, GM00468)
show hybridization to both the expected 5.5kb fragment and the aberrant 7kb fragment.
These two fibroblast cell lines therefore show heterozygous deletion for the sequences that
are homozygously deleted in HeLa cells. F) FISH analysis using the 5.5kb probe sequence
shows hybridization to the 11q13.1 locus in a normal lymphocyte as indicated by the arrows
(top left panel). Fibroblast cell line GM00077 contains two copies of the control probe
HRAS, (11p15) and only one copy of the 5.5kb probe (top right panel). The inset again
shows the hybridization of a single copy of the 11q13.1 probe. The results therefore suggest
heterozygous deletion of the 5.5kb sequences in this cell line. The HeLa cells (bottom
panels). show hybridization to the control 11p15- HRAS and 11q23-MLL probes (bold
arrows), left and right panels respectively, but no hybridization to the 5.5kb probe,
indicating homozygous deletion of the 5.5kb probe sequences (bottom panels).
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Heterozygous deletion of 5.5kb sequences in constitutional lymphocyte samples. A) Long
range PCR carried out on lymphocyte DNAs shows the presence of the expected 7.3kb
product in samples 1 and 2. Samples 30, 86, 89, 98 and 108 show the presence of 7.3kb and
1.8kb products indicating the loss of 5.5kb sequence from one of the copies of chromosome
11. Here, the fibroblast cell line GM00077 containing the heterozygous deletion (see Figure
2 above) and HeLa (D98/AH-2) cells containing the 5.5kb homozygous deletion (presence
of only the 1.8kb PCR product) are used as controls. The intensity of the 1.8kb product is
higher due to preferential amplification of the smaller product. B) A Semi-quantitative PCR
shows the intensity ratio of contig 282789/CA54481 in deleted samples to be half of that in
non-deleted samples confirming heterozygous deletion. C) Southern blot hybridization
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shows the expected 7kb and 5.5kb fragments in four of the samples containing heterozygous
deletion. Two of the lymphocyte samples without deletion contain the expected 5.5kb
fragment. HeLa cells show the presence of the 7kb fragment (indicated by the arrow)
confirming homozygous deletion of the 5.5kb sequences. D) PCR analysis on the test case
African-American (AA) samples shows homozygous deletion of the 5.5kb sequence in two
of the AA samples, AA2 and AA30. E) Southern blot hybridization confirms the presence of
homozygous deletion (presence of only the 7kb fragment –indicated by the arrow) in these
two samples. Three other samples (AA33, AA34, AA52) contain heterozygous deletion. F)
Long range PCR shows heritability of the 5.5kb deletion (presence of 1.8kb fragment) in a
2-generation African ancestral cystic fibrosis family. The proband (crossed circle) and the
two affected brothers (dark squares) are also shown.
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Reported copy number variations overlapping the 5.5kb region are found to exist primarily
in the Yoruba (YRI) population. A) The UCSC Genome Browser (hg 18) showing eight
copy number variations from the Database of Genomic Variants that overlap with the
queried region (deletions = red, duplications = blue). Each CNV has a unique identifier (in
green). B) Information pertaining to each variation ID shows that the copy number
variations in this region are found primarily in the Yoruba population.
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A.) Plot of r2 values for SNPs on Chromosome 11 in the YRI HapMap3 population. Five
SNPs have r2 values = 1 conveying strong LD with the 5.5kb deletion. A zoomed in view of
the plot is also present to show the positions of the SNPs relative to the deletion and PACS1.
B) A table listing the five SNPs with strong LD and their positions on chromosome 11.
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Repeat content, thermodynamic stability and flexibility of the tumor suppressor locus. A) A
700kb region surrounding the HeLa cell homozygous deletion was divided into 20kb
segments and analyzed for repeat and GC content by REPEATMASKER. A rise in overall
repeat content, especially in LINE1 elements, and a drop in GC content are observed for a
120kb region surrounding D11S913 (indicated by black horizontal bar). B) An overlapping
175kb region shows absence of stability peaks, indicating that these sequences are
thermodynamically unstable than the surrounding sequences (p<0.001; t-test). C)
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TWISTFLEX analysis shows that the 175kb sequence contains a significant increase in
overall DNA flexibility as compared to the surrounding sequences (p<0.001; t-test). These
characteristics are seen in other common fragile sites of the human genome.
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Secondary structures for the 120kb unstable, flexible, repeat rich sequences as predicted by
MFold. A) Map of the 120kb interval detailing the presence of each of the 44 secondary
structures. The colored arrows represent the location of the inverted repeats contributing to
secondary structures. One inverted repeat can interact with multiple other repeats to form
several possible secondary structures. B) A representative sequence of one of the secondary
structures contains two inverted Alu repeats located at the 5’ and 3’ end of the sequence. C)
The predicted secondary structure for the above sequence. Alu repeats provide the inverted
sequences that help stabilize this stem-loop structure. Such structures are shown to be
responsible for fragile site induction (7). D) A large secondary structure for the region 63kb
– 69kb which contains numerous over-lapping and nested inverted repeats. The sequences of
this structure contain a series of SINE and LINE inverted repeats, demonstrating how
multiple inverted repeats can stabilize structures that span several kilobases.
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Table 1
Deletion frequency of 5.5kb sequence in the general population
Ancestry Samples Deletions Deletion
analyzed frequency (%)
Total 494 47 9.50
Caucasian 126 6 4.76
African American 92 26 28.30
JPT/CHB 17 0 0
Mixed/not-provided 259 15 5.79
p-value <0.0001, calculated for AA population with respect to Caucasian population. The data above indicates that 1) heterozygous deletion is a
common event in the general population and 2) higher frequency of deletion is observed in people of African American ancestry compared to those
of Caucasian ancestry (28.3% vs 4.76%).
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